Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (10): 1417-1429.doi: 10.12092/j.issn.1009-2501.2026.10.013
Haiyi NIE1(
), Qi GUO1, Huanhuan ZHANG1, Zhangbo SONG1, Mengyuan WU1, Zhiming MIAO1, Yangyang LI1, Pin LIU2, Wenxing YONG3,*(
), Liying ZHANG1,*(
)
Received:2025-09-17
Revised:2026-05-09
Online:2026-10-26
Published:2026-11-11
Contact:
Wenxing YONG,Liying ZHANG
E-mail:3301880775@qq.com;1473124396@qq.com;zhangliying201212@163.com
CLC Number:
Haiyi NIE, Qi GUO, Huanhuan ZHANG, Zhangbo SONG, Mengyuan WU, Zhiming MIAO, Yangyang LI, Pin LIU, Wenxing YONG, Liying ZHANG. Regulatory role of exosome in the inflammatory mechanism of COPD and research progress of drug intervention[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(10): 1417-1429.
| 药物 | 外泌体来源 | 靶向RNA | 作用机制 | 参考文献 | |
| 中药(单体及有效成分) | 人参皂苷 | 小鼠树突细胞(DC) | miR-695 | 通过上调DC外泌体中的miRNA-695,抑制PI3K/AKT信号通路,发挥抗炎作用 | [ |
| 丹参酮 | 人支气管上皮16HBE细胞 | miR-486-5p | 通过上调支气管上皮细胞来源的外泌体中的miR-486-5p来靶向PIK3R1,抑制PI3K信号通路,发挥抗炎作用 | [ | |
| 黄芪甲苷 | 大鼠肺泡上皮细胞 | miR-21-5p | 通过上调miR-21-5p抑制NF-κB信号通路的激活,治疗COPD | [ | |
| 西药 | 簇分化抗原24(CD24) | 小鼠支气管肺泡灌洗液中的细胞组成,对T和B淋巴细胞、嗜酸性粒细胞、中性粒细胞、树突状细胞和单核细胞/巨噬细胞进行支气管肺泡灌洗液(BALF) | EXO-CD24 | CD24通过与DAMP结合,阻止它们与模式识别受体(PRR)(例如TLR、NLR)相互作用,从而抑制NF-?B通路的激活 | [ |
| 皮质类固醇(ICS) | COPD患者的支气管肺泡灌洗液 | miR-320d | miR-320d通过调节IL-1β诱导的NF-κB信号通路发挥抗炎miRNA的作用 | [ | |
| MSC衍生产品(Exo-d-MAPPS) | 小鼠肺泡上皮细胞 | 可溶性抗炎介质(sTNFRⅠ和Ⅱ、IL-1Ra和sRAGE) | Exo-d-MAPPS通过可溶性介质下调IL-17A和IFNγ等炎症因子,降低M1巨噬细胞的数量。 | [ | |
Table 1 Exosome-mediated signaling pathways involved in the treatment of COPD inflammatory response by drugs
| 药物 | 外泌体来源 | 靶向RNA | 作用机制 | 参考文献 | |
| 中药(单体及有效成分) | 人参皂苷 | 小鼠树突细胞(DC) | miR-695 | 通过上调DC外泌体中的miRNA-695,抑制PI3K/AKT信号通路,发挥抗炎作用 | [ |
| 丹参酮 | 人支气管上皮16HBE细胞 | miR-486-5p | 通过上调支气管上皮细胞来源的外泌体中的miR-486-5p来靶向PIK3R1,抑制PI3K信号通路,发挥抗炎作用 | [ | |
| 黄芪甲苷 | 大鼠肺泡上皮细胞 | miR-21-5p | 通过上调miR-21-5p抑制NF-κB信号通路的激活,治疗COPD | [ | |
| 西药 | 簇分化抗原24(CD24) | 小鼠支气管肺泡灌洗液中的细胞组成,对T和B淋巴细胞、嗜酸性粒细胞、中性粒细胞、树突状细胞和单核细胞/巨噬细胞进行支气管肺泡灌洗液(BALF) | EXO-CD24 | CD24通过与DAMP结合,阻止它们与模式识别受体(PRR)(例如TLR、NLR)相互作用,从而抑制NF-?B通路的激活 | [ |
| 皮质类固醇(ICS) | COPD患者的支气管肺泡灌洗液 | miR-320d | miR-320d通过调节IL-1β诱导的NF-κB信号通路发挥抗炎miRNA的作用 | [ | |
| MSC衍生产品(Exo-d-MAPPS) | 小鼠肺泡上皮细胞 | 可溶性抗炎介质(sTNFRⅠ和Ⅱ、IL-1Ra和sRAGE) | Exo-d-MAPPS通过可溶性介质下调IL-17A和IFNγ等炎症因子,降低M1巨噬细胞的数量。 | [ | |
| 1 | Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2025 report [M]. Geneva: World Health Organization, 2025. |
| 2 |
Lin S, Ding X, Dang X, et al. Global, regional, and national disease burden of pneumoconiosis, chronic obstructive pulmonary disease, tracheal-bronchus-and-lung cancer, and asthma attributable to occupational risks, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Front Public Health, 2025, 13, 1652216.
doi: 10.3389/fpubh.2025.1652216 |
| 3 |
Weng J, Zhang H, Chang Q, et al. Fibrinogen gamma chain mediates airway inflammation and remodeling through the focal adhesion and TGF-β/Smad2 pathways in chronic obstructive pulmonary disease[J]. Lung, 2025, 203 (1): 100.
doi: 10.1007/s00408-025-00856-w |
| 4 |
Chen J, Wang T, Li X, et al. DNA of neutrophil extracellular traps promote NF-κB-dependent autoimmunity via cGAS/TLR9 in chronic obstructive pulmonary disease[J]. Signal Transduct Target Ther, 2024, 9 (1): 163.
doi: 10.1038/s41392-024-01881-6 |
| 5 |
Qi L, Luo DZ, Li H, et al. Macrophage-driven exosomes regulate the progression of cardiovascular disease[J]. Front Pharmacol, 2025, 16, 1563800.
doi: 10.3389/fphar.2025.1563800 |
| 6 | Wang X, Deng Z, Wang Z, et al. Engineered MSC-exosomes delivering miRNAs for respiratory disease diagnostics and therapy: opportunities and challenges[J]. Int J Nanomedicine, 2026, 21, 560737. |
| 7 |
Mohan A, Agarwal S, Clauss M, et al. Extracellular vesicles: novel communicators in lung diseases[J]. Respir Res, 2020, 21 (1): 175.
doi: 10.1186/s12931-020-01423-y |
| 8 |
Arya SB, Collie SP, Parent CA. The ins-and-outs of exosome biogenesis, secretion, and internalization[J]. Trends Cell Biol, 2024, 34 (2): 90- 108.
doi: 10.1016/j.tcb.2023.06.006 |
| 9 |
Karabay AZ, Barar J, Hekmatshoar Y, et al. Multifaceted therapeutic potential of plant-derived exosomes: immunomodulation, anticancer, anti-aging, anti-melanogenesis, detoxification, and drug delivery[J]. Biomolecules, 2025, 15 (3): 394.
doi: 10.3390/biom15030394 |
| 10 |
Lv J, Xiong X. Extracellular vesicle microRNA: a promising biomarker and therapeutic target for respiratory diseases[J]. Int J Mol Sci, 2024, 25 (17): 9236.
doi: 10.3390/ijms25179236 |
| 11 |
Wu Y, Wang Y, Zhou J, et al. How advanced are exosomes as cell-free therapeutics for spinal cord injury?[J]. Int J Nanomedicine, 2025, 20, 11669- 11683.
doi: 10.2147/IJN.S536652 |
| 12 |
Yu D, Li Y, Wang M, et al. Exosomes as a new frontier of cancer liquid biopsy[J]. Mol Cancer, 2022, 21 (1): 56.
doi: 10.1186/s12943-022-01509-9 |
| 13 | Sunds C, Chang HH. Extracellular vesicles: function, resilience, biomarker, bioengineering, and clinical implications[J]. Tzu Chi Med J, 2024, 36 (3): 251- 259. |
| 14 |
Yu A, Zhang Y, Zhong S, et al. Human umbilical cord mesenchymal stem cell-derived exosomes enhance follicular regeneration in androgenetic alopecia via activation of Wnt/β-catenin pathway[J]. Stem Cell Res Ther, 2025, 16 (1): 418.
doi: 10.1186/s13287-025-04538-5 |
| 15 |
Jackson Cullison SR, Flemming JP, Karagoz K, et al. Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics[J]. J Extracell Biol, 2024, 3 (11): e70017.
doi: 10.1002/jex2.70017 |
| 16 |
Zhang W, Zhou B, Yang X, et al. Exosomal circEZH2_005, an intestinal injury biomarker, alleviates intestinal ischemia/reperfusion injury by mediating Gprc5a signaling[J]. Nat Commun, 2023, 14 (1): 5437.
doi: 10.1038/s41467-023-41147-3 |
| 17 |
芮玉娟, 段雯慧, 朱彤彤, 等. 间充质干细胞及其外泌体在慢性阻塞性肺疾病治疗中的研究进展[J]. 中国呼吸与危重监护杂志, 2025, 24 (9): 680- 684.
doi: 10.7507/1671-6205.202410072 |
| 18 |
黄宁, 胡长平. 外泌体在肺部疾病中的研究进展[J]. 中国药理学通报, 2023, 39 (11): 2006- 2011.
doi: 10.12360/CPB202204136 |
| 19 |
Zhu Z, Zhang X, Lin X, et al. Research advances and application progress on miRNAs in exosomes derived from M2 macrophage for tissue injury repairing[J]. Int J Nanomedicine, 2025, 20, 1543- 1560.
doi: 10.2147/IJN.S508781 |
| 20 |
Xu H, Li X, Liu K, et al. PM2.5 promotes macrophage-mediated inflammatory response through airway epithelial cell-derived exosomal miR-155-5p[J]. J Inflamm Res, 2024, 17, 8555- 8567.
doi: 10.2147/JIR.S482509 |
| 21 |
刘路, 齐文川, 曾倩, 等. 基于外泌体介导的巨噬细胞极化探讨针刺治疗慢性阻塞性肺疾病的潜在机制[J]. 南京中医药大学学报, 2023, 39 (1): 93- 100.
doi: 10.14148/j.issn.1672-0482.2023.0093 |
| 22 |
Tan DBA, Armitage J, Teo TH, et al. Elevated levels of circulating exosome in COPD patients are associated with systemic inflammation[J]. Respir Med, 2017, 132, 261- 264.
doi: 10.1016/j.rmed.2017.04.014 |
| 23 |
Moon HG, Kim SH, Gao J, et al. CCN1 secretion and cleavage regulate the lung epithelial cell functions after cigarette smoke[J]. Am J Physiol Lung Cell Mol Physiol, 2014, 307 (4): L326- L337.
doi: 10.1152/ajplung.00102.2014 |
| 24 |
Fan H, Zhao H, Gao L, et al. CCN1 enhances tumor immunosuppression through collagen-mediated chemokine secretion in pancreatic cancer[J]. Adv Sci (Weinh), 2025, 12 (23): e2500589.
doi: 10.1002/advs.202500589 |
| 25 |
Xue C, Chu Q, Shi Q, et al. Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances[J]. Signal Transduct Target Ther, 2025, 10 (1): 106.
doi: 10.1038/s41392-025-02142-w |
| 26 |
Kotsiou OS, Katsanaki K, Tsiggene A, et al. Detection and characterization of extracellular vesicles in sputum samples of COPD patients[J]. J Pers Med, 2024, 14 (8): 820.
doi: 10.3390/jpm14080820 |
| 27 | Wang L, Chen H, Du Y, et al. Yiqi Zishen formula ameliorates inflammation in mice with chronic obstructive pulmonary disease by inhibiting the PI3K/Akt/NF-κB signaling pathway[J]. J South Med Univ, 2025, 45 (7): 1409- 1422. |
| 28 |
杨洋, 李竹英, 田春燕, 等. 中医药干预慢性阻塞性肺疾病相关信号通路的研究进展[J]. 中国实验方剂学杂志, 2024, 30 (15): 244- 255.
doi: 10.13422/j.cnki.syfjx.20241021 |
| 29 |
Ning Y, Huang L, Wang QQ, et al. Hederasaponin C ameliorates chronic obstructive pulmonary disease pathogenesis by targeting TLR4 to inhibit NF-κB/MAPK signaling pathways[J]. Chin Med, 2025, 20 (1): 104.
doi: 10.1186/s13020-025-01155-5 |
| 30 |
Wu JJ, Zhang PA, Chen MZ, et al. Network pharmacology and experimental validation of Jinwei Decoction for enhancement of glucocorticoid anti-inflammatory effect in COPD through miR-155-5p[J]. Comb Chem High Throughput Screen, 2025, 28 (2): 351- 370.
doi: 10.2174/0113862073279344240215050056 |
| 31 |
Carpi S, Polini B, Nieri D, et al. Extracellular vesicles induce nuclear factor-κB activation and interleukin-8 synthesis through miRNA-191-5p contributing to inflammatory processes: potential implications in the pathogenesis of chronic obstructive pulmonary disease[J]. Biomolecules, 2024, 14 (8): 1030.
doi: 10.3390/biom14081030 |
| 32 |
Shen Y, Wang L, Wu Y, et al. A novel diagnostic signature based on three circulating exosomal microRNAs for chronic obstructive pulmonary disease[J]. Exp Ther Med, 2021, 22 (1): 717.
doi: 10.3892/etm.2021.10149 |
| 33 |
Zhang AQ, Qian FY, Li YY, et al. Research progress of metformin in the treatment of liver fibrosis[J]. Int Immunopharmacol, 2023, 116, 109738.
doi: 10.1016/j.intimp.2023.109738 |
| 34 |
Liu JH, Li C, Cao L, et al. Exosomal miR-132-3p from mesenchymal stem cells alleviated LPS-induced acute lung injury by repressing TRAF6[J]. Autoimmunity, 2021, 54 (8): 493- 503.
doi: 10.1080/08916934.2021.1966768 |
| 35 |
Wang Y, Zhu J, Chen J, et al. The signaling pathways induced by exosomes in promoting diabetic wound healing: a mini-review[J]. Curr Issues Mol Biol, 2022, 44 (10): 4960- 4976.
doi: 10.3390/cimb44100337 |
| 36 |
Chen Q, Lin J, Deng Z, et al. Exosomes derived from human umbilical cord mesenchymal stem cells protect against papain-induced emphysema by preventing apoptosis through activating VEGF-VEGFR2-mediated AKT and MEK/ERK pathways in rats[J]. Regen Ther, 2022, 21, 216- 224.
doi: 10.1016/j.reth.2022.07.002 |
| 37 |
Parveen S, Fatma M, Mir SS, et al. JAK-STAT signaling in autoimmunity and cancer[J]. Immunotargets Ther, 2025, 14, 523- 554.
doi: 10.2147/ITT.S485670 |
| 38 |
Dorjsembe B, Joo H, Nho C, et al. Aruncus dioicus var. kamtschaticus extract ameliorates psoriasis-like skin inflammation via AKT/mTOR and JAK2/STAT3 signaling pathways in a murine model[J]. Nutrients, 2022, 14 (23): 5094.
doi: 10.3390/nu14235094 |
| 39 |
Wang CY, Ding HZ, Tang X, et al. Liuwei Buqi capsules suppress inflammation by affecting T cell polarization and survival in chronic obstructive pulmonary disease[J]. Med Chem Res, 2017, 26 (11): 2816- 2823.
doi: 10.1007/s00044-017-1980-0 |
| 40 |
Silva LF, Lourenço JD, Silva KR, et al. Th17/Treg imbalance in COPD development: suppressors of cytokine signaling and signal transducers and activators of transcription proteins[J]. Sci Rep, 2020, 10 (1): 15287.
doi: 10.1038/s41598-020-72305-y |
| 41 |
Jia H, He W, Wu B, et al. Cigarette smoke-induced exosomal miR-221-3p facilitates M1 macrophage polarization via the STAT3 pathway in chronic obstructive pulmonary disease[J]. Aging (Albany NY), 2024, 16 (17): 12379- 12391.
doi: 10.18632/aging.206095 |
| 42 |
Campos-Mora M, Desolmini HACJ, Rojas C, et al. Neuropilin-1 is present on Foxp3+ T regulatory cell-derived small extracellular vesicles and mediates immunity against skin transplantation[J]. J Extracell Vesicles, 2022, 11 (6): e12237.
doi: 10.1002/jev2.12237 |
| 43 |
Tao X, Tian H, Wang G, et al. Exosomes from Tregs mitigate lung damage caused by smoking via inhibiting inflammation and altering T lymphocyte subsets in COPD rats[J]. BMC Pulm Med, 2025, 25 (1): 181.
doi: 10.1186/s12890-025-03632-x |
| 44 |
Hu DJ, Cai XT, Simons J, et al. Non-canonical Wnt signaling promotes epithelial fluidization in the repairing airway[J]. Nat Commun, 2025, 16 (1): 4124.
doi: 10.1038/s41467-025-59320-1 |
| 45 |
Chen J, Chen J, Cheng Y, et al. Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation[J]. Stem Cell Res Ther, 2020, 11 (1): 97.
doi: 10.1186/s13287-020-01610-0 |
| 46 | Song Q, Zhou A, Cheng W, et al. Bone marrow mesenchymal stem cells-derived exosomes inhibit apoptosis of pulmonary microvascular endothelial cells in COPD mice through miR-30b/Wnt5a pathway [J]. Int J Nanomedicine, 2025, 20: 1191-1211. |
| 47 |
Zhang J, Lin R, Li Y, et al. A large-scale production of mesenchymal stem cells and their exosomes for an efficient treatment against lung inflammation[J]. Biotechnol J, 2024, 19 (2): e2300174.
doi: 10.1002/biot.202300174 |
| 48 |
Huang Y, Huang J, Zhan J, et al. CCN1 is a therapeutic target upregulated in EML4-ALK mutant lung adenocarcinoma reversibly resistant to alectinib[J]. Cell Death Dis, 2025, 16 (1): 303.
doi: 10.1038/s41419-025-07601-4 |
| 49 |
Liu S, Tan X, Liu S. The role of extracellular vesicles in COPD and potential clinical value[J]. Respir Res, 2024, 25 (1): 84.
doi: 10.1186/s12931-024-02719-z |
| 50 | Cheng X, Wang P, Lyu H, et al. Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance[J]. Cancer Drug Resist, 2025, 8, 46. |
| 51 |
Benak D, Alanova P, Holzerova K, et al. Epitranscriptomic regulation of HIF-1: bidirectional regulatory pathways[J]. Mol Med, 2025, 31 (1): 105.
doi: 10.1186/s10020-025-01149-x |
| 52 | Semenza GL. Hypoxia-inducible factors in physiology and medicine[J]. Cell, 2012, 148 (2): 399- 408. |
| 53 |
Zhao C, Huang Y, Zhang H, et al. CD24 affects the immunosuppressive effect of tumor-infiltrating cells and tumor resistance in a variety of cancers[J]. Discov Oncol, 2024, 15 (1): 399.
doi: 10.1007/s12672-024-01284-7 |
| 54 |
Liu Y, Zheng P. CD24: a genetic checkpoint in T cell homeostasis and autoimmune diseases[J]. Trends Immunol, 2007, 28 (7): 315- 320.
doi: 10.1016/j.it.2007.05.001 |
| 55 |
Liu Y, Zheng P. CD24-Siglec interactions in inflammatory diseases[J]. Front Immunol, 2023, 14, 1174789.
doi: 10.3389/fimmu.2023.1174789 |
| 56 |
Shapira S, Schwartz R, Tsiodras S, et al. Inhaled CD24-enriched exosomes (EXO-CD24) as a novel immune modulator in respiratory disease[J]. Int J Mol Sci, 2023, 25 (1): 77.
doi: 10.3390/ijms25010077 |
| 57 |
Faiza, Steiling K, Roffel MP, et al. Effect of long-term corticosteroid treatment on microRNA and gene-expression profiles in COPD[J]. Eur Respir J, 2019, 53 (4): 1801202.
doi: 10.1183/13993003.01202-2018 |
| 58 |
Du YM, Sun YXZ, Chen R, et al. Mesenchymal stem cell exosomes promote immunosuppression of regulatory T cells in asthma[J]. Exp Cell Res, 2018, 363 (1): 114- 120.
doi: 10.1016/j.yexcr.2017.12.021 |
| 59 |
杨岩涛, 杨岩, 肖佳妹, 等. 人参皂苷Rg1促血管生成及其血管保护作用研究进展[J]. 药学学报, 2021, 56 (8): 2146- 2153.
doi: 10.16438/j.0513-4870.2021-0107 |
| 60 | Guan SB, Yu P, Cao JH, et al. Ginsenoside Rg1 protects against cigarette smoke-induced airway remodeling by suppressing the TGF-β1/Smad3 signaling pathway[J]. Am J Transl Res, 2020, 12 (2): 493- 506. |
| 61 |
Luo D, Liu J, Ya L, et al. Cigarette smoke exposure triggers dendritic cell-derived exosome-mediated Th17 and Treg polarization through an autophagy- and necroptosis-associated SIRT1-dependent mechanism in vitro[J]. Front Immunol, 2026, 16, 1715736.
doi: 10.3389/fimmu.2025.1715736 |
| 62 |
谢淑敏, 郭淑杰, 薛丙权, 等. 基于树突细胞外泌体miRNA探究人参皂苷Rg1改善COPD的作用机制[J]. 中国医院药学杂志, 2025, 45 (10): 1140- 1146.
doi: 10.13286/j.1001-5213.2025.10.08 |
| 63 |
Ding W, Xu S, Xie S, et al. Danshensu ethyl ester alleviates LPS-induced acute lung injury by targeting the NLRP3 inflammasome[J]. J Inflamm Res, 2025, 18, 8767- 8785.
doi: 10.2147/JIR.S517701 |
| 64 |
Xu M, Cao F, Liu L, et al. Tanshinone IIA-induced attenuation of lung injury in endotoxemic mice is associated with reduction of hypoxia-inducible factor 1α expression[J]. Am J Respir Cell Mol Biol, 2011, 45 (5): 1028- 1035.
doi: 10.1165/rcmb.2011-0113OC |
| 65 |
Tian D, Miao Y, Hao W, et al. Tanshinone IIA protects against chronic obstructive pulmonary disease via exosome-shuttled miR-486-5p[J]. Int J Mol Med, 2022, 50 (1): 97.
doi: 10.3892/ijmm.2022.5153 |
| 66 |
赵佳琛, 王艺涵, 金艳, 等. 经典名方中黄芪的本草考证[J]. 中国实验方剂学杂志, 2022, 28 (10): 337- 346.
doi: 10.13422/j.cnki.syfjx.20211659 |
| 67 |
徐维佳, 陈揭剑, 严丽群, 等. 黄芪甲苷对马兜铃酸诱导的巨噬细胞M1型极化的作用及机制研究[J]. 现代生物医学进展, 2021, 21 (6): 1040.
doi: 10.13241/j.cnki.pmb.2021.06.009 |
| 68 |
Li H, Yao C, Shi K, et al. Astragaloside IV attenuates hypoxia/reoxygenation injury-induced apoptosis of type II alveolar epithelial cells through miR-21-5p[J]. Bioengineered, 2021, 12 (1): 7747- 7754.
doi: 10.1080/21655979.2021.1982845 |
| 69 |
Jin T, Liu X, Li G, et al. Intravenous injection of BMSCs modulates tsRNA expression and ameliorate lung remodeling in COPD mice[J]. Stem Cell Res Ther, 2024, 15 (1): 450.
doi: 10.1186/s13287-024-04066-8 |
| 70 |
Fujioka N, Kitabatake M, Ouji-Sageshima N, et al. Human adipose-derived mesenchymal stem cells ameliorate elastase-induced emphysema in mice by mesenchymal-epithelial transition[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16, 2783- 2793.
doi: 10.2147/COPD.S324952 |
| 71 | Michaeloudes C, Li X, Mak JCW, et al. Study of mesenchymal stem cell-mediated mitochondrial transfer in vitro models of oxidant-mediated airway epithelial and smooth muscle cell injury[J]. Methods Mol Biol, 2021, 2269, 93- 105. |
| 72 |
Varricchi G, Ferri S, Pepys J, et al. Biologics and airway remodeling in severe asthma[J]. Allergy, 2022, 77 (12): 3538- 3552.
doi: 10.1111/all.15473 |
| 73 |
Feng CY, Bai SY, Li ML, et al. Adipose-derived mesenchymal stem cell-derived exosomal miR-301a-3p regulates airway smooth muscle cells during asthma by targeting STAT3[J]. J Asthma Allergy, 2022, 15, 99- 110.
doi: 10.2147/JAA.S335680 |
| 74 |
Shan L, Liu S, Zhang Q, et al. Human bone marrow-mesenchymal stem cell-derived exosomal microRNA-188 reduces bronchial smooth muscle cell proliferation in asthma through suppressing the JARID2/Wnt/beta-catenin axis[J]. Cell Cycle, 2022, 21 (4): 352- 367.
doi: 10.1080/15384101.2021.2020432 |
| 75 |
Tang H, Han X, Li T, et al. Protective effect of miR-138-5p inhibition modified human mesenchymal stem cell on ovalbumin-induced allergic rhinitis and asthma syndrome[J]. J Cell Mol Med, 2021, 25 (11): 5038- 5049.
doi: 10.1111/jcmm.16473 |
| 76 |
Zhai Z, Cui T, Chen J, et al. Advancements in engineered mesenchymal stem cell exosomes for chronic lung disease treatment[J]. J Transl Med, 2023, 21 (1): 895.
doi: 10.1186/s12967-023-04729-9 |
| 77 |
Hou L, Zhu Z, Jiang F, et al. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles alleviated silica induced lung inflammation and fibrosis in mice via circPWWP2A/miR-223-3p/NLRP3 axis[J]. Ecotoxicol Environ Saf, 2023, 251, 114537.
doi: 10.1016/j.ecoenv.2023.114537 |
| 78 |
Hong H, Wu Y, Li Y, et al. Endothelial PPARδ ablation exacerbates vascular hyperpermeability via STAT1/CXCL10 signaling in acute lung injury[J]. Circ Res, 2025, 136 (7): 735- 751.
doi: 10.1161/CIRCRESAHA.124.325855 |
| 79 |
Liu JS, Du J, Cheng X, et al. Exosomal miR-451 from human umbilical cord mesenchymal stem cells attenuates burn-induced acute lung injury[J]. J Chin Med Assoc, 2019, 82 (12): 895- 901.
doi: 10.1097/JCMA.0000000000000189 |
| 80 |
Liu J, Xing F, Fu Q, et al. hUC-MSCs exosomal miR-451 alleviated acute lung injury by modulating macrophage M2 polarization via regulating MIF-PI3K-AKT signaling pathway[J]. Environ Toxicol, 2022, 37 (12): 2819- 2831.
doi: 10.1002/tox.23639 |
| 81 |
Wang J, Huang R, Xu Q, et al. Mesenchymal stem cell-derived extracellular vesicles alleviate acute lung injury via transfer of miR-27a-3p[J]. Crit Care Med, 2020, 48 (7): e599- e610.
doi: 10.1097/CCM.0000000000004315 |
| [1] | Xinxin YIN, Changpeng XIE, Xuejing LI, Liping ZHANG, Zhanhai SU, Haiyan WANG, Qiong WU, Yuanming PAN, Juan AN. Mechanism of stem cell exosome-mediated repair of hepatocyte injury via mitochondrial and fatty acid metabolism [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(9): 1162-1172. |
| [2] | Shiya WU, Xiaodan LIU, Yan HU, Qi LIN. Correlation analysis between tigecycline therapeutic concentration monitoring and adverse reactions [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(9): 1238-1248. |
| [3] | Shuling SHAO, Jiawen WU. Research progress on endocrine-regulating mechanisms and active components of classical prescriptions in the treatment of hypertension [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(9): 1275-1285. |
| [4] | Chengzhi WANG, Songwei LI, Yifan LIU, Mengmeng DU, Keying ZHU, Huan LI. Research progress on the mechanism of miRNA in regulating primary Sjögren's syndrome [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(8): 1091-1100. |
| [5] | Jianxin YANG, Yunli YU. Pharmacokinetic/pharmacodynamic characteristics of adalimumab in moderate-to-severe psoriasis and its therapeutic drug monitoring applications [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(7): 921-927. |
| [6] | Sihan LU, Guanglin BAO, Jianguo SUN. Novel in vitro liver metabolism models and their applications progress [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(7): 975-989. |
| [7] | Shunfang ZUO, Huali XU, Linyu LI, Tianlang LI, Wenwen FU, Yan XUE. Cold exposure-induced pathophysiological changes and related diseases: recent advances [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(7): 990-1000. |
| [8] | Xuewu LIU, Dejian JIANG, Yanhua DU. Progress in pathogenesis and drug development of diabetic kidney disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(6): 735-751. |
| [9] | Xiao XU, Shuailin WANG, Xin QIAN, Yi YAO, Zhangyu WANG, Xiaoyi ZHU, Qing MAO, Qi GUO. Research progress on the treatment of diabetic cardiomyopathy with traditional Chinese medicine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(6): 764-773. |
| [10] | Xinyun PAN, Yunjian SONG, Zhongqun WANG. Research progress on macrophage membrane nanoparticles in the treatment of diabetic cardiovascular complications [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(6): 821-826. |
| [11] | Ailin LU, Mengrui YUAN, Yongqing WU, Hongyi LIU. Progress of Chinese medicine intervention in HMGB1 pathway to improve type 2 diabetes mellitus and its complications [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(6): 827-835. |
| [12] | Zongfeng WEI, Jinlong TAN, Menghan SUN, Nailiang ZHU, Yingying ZHAI, Qiong CHEN, Jingjing BI, Lixiang LIANG, Min SONG. Mechanism study of Processed Pinellia ternata alleviating COPD injury through macrophages and fibroblasts Crosstalk [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(5): 585-595. |
| [13] | Xiaying WANG, Hugang JIANG, Chunzhen REN, Jing MA, Jiakun LIU, Kai LIU, Yingdong LI, Xinke ZHAO. Construction strategy and application of an in vitro model of radioactive cardiac injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(5): 639-648. |
| [14] | Qun LI, Xinyue ZHANG, Shuo QI, Jin TAN. Research progress on the mechanism of TGF-β1/Smads signaling pathway in oral submucous fibrosis and regulation of traditional Chinese medicine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(5): 666-674. |
| [15] | Jiaxian ZHANG, Jian XIAO, Hangxing HUANG, Mengyao LI, Ting YU, Huimin YU, Jingyang LI, Lei NING, Ying WANG. Drug-related problems and its associated factors among outpatients with COPD: A cross sectional retrospective study [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(4): 474-485. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||